Clinical trial
Can Oral Benfotiamine Supplementation Influence Progression of Microvascular Complications in Patients With Type 1 Diabetes?
NCT00117026 is registered in ClinicalTrials.gov with University Hospital, Aker as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Oral Benfotiamine Supplementation Influence Progression of Microvascular Complications in Patients With Type 1 Diabetes?
- Lead sponsor
- University Hospital, Aker
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- February 28, 2011
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.